REG - Inspiration Health - CFO appointment

Inspiration HealthcareAnnouncement

12/06/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230612:nRSL3218Ca&default-theme=true

RNS Number : 3218C  Inspiration Healthcare Group PLC  12 June 2023

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

 

Appointment of Chief Financial Officer

and

Grant of Options

 

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology
company pioneering best-in class, specialist neonatal intensive care medical
devices, announces the appointment of Alan Olby ACA as Chief Financial Officer
and a Director of the Company, effective immediately.

 

Alan is an experienced and commercially focused healthcare CFO, with extensive
international and operational experience within fast-growing listed and
private healthcare companies. He spent 16 years at Sinclair Pharma, of which
12 years were as CFO and a member of the executive leadership team and he was
instrumental in transforming the company into a fast growth global aesthetics
business, which was sold to Huadong Medicine Co Ltd for £165 million in 2018.

 

During his tenure he oversaw several successful capital raises, and a number
of strategic M&A transactions, including the disposal of the non-core
business to Alliance Pharma for £132 million in 2015. Prior to Sinclair
Pharma, Alan was Group Financial Controller of Xenova Group plc and KS
Biomedix plc.

 

Neil Campbell, Chief Executive Officer of Inspiration Healthcare said: "We are
delighted to have someone of Alan's calibre join Inspiration Healthcare. His
track record of building and growing a commercial healthcare business and his
experience of capital markets will be invaluable as we continue to execute our
strategy and build a world leading innovative medical technology company
focused on neonatal intensive care."

 

Alan Olby, incoming Chief Financial Officer commented: "I am delighted to be
joining Inspiration Healthcare at this exciting stage in the Group's
development. The Group's world class design and manufacturing expertise
enables it to provide a broad range of specialist, innovative products that
address the critical needs within the global neonatal market and I look
forward to working to accelerate the Group's growth strategy."

 

In accordance with Schedule 2 (g) of the AIM Rules for Companies, Alan
Musgrave Olby (aged 52 years) holds/has held the following
directorships/partnerships in the last five years:

 Current directorships/partnerships  Previous directorships/partnerships (last five years)
 None                                Acorus Therapeutics Limited
                                     Aqtis Medical BV
                                     Cocoon Medical Italy SRL

                                     Cocoon Medical Colombia SAS

                                     Cocoon Medical Hong Kong Limited

                                     Cocoon Medical International EOOD

                                     Cocoon Medical USA LLC
                                     High Technology Products SL
                                     IS Pharma Limited
                                     IS Pharmaceuticals Limited

                                     Sinclair Aesthetics De Mexico S.A. De C.V.

                                     Sinclair Chile SPA

                                     Sinclair Korea Limited
                                     Silhouette Lift SL
                                     Sinclair France SAS
                                     Sinclair Holding BV
                                     Sinclair Holdings Iberia SL
                                     Sinclair Netherlands IP BV
                                     Sinclair Pharma GmbH
                                     Sinclair Pharma Holdings Limited
                                     Sinclair Pharma Limited
                                     Sinclair Pharma Man Co Limited
                                     Sinclair Pharma Management Limited
                                     Sinclair Pharmaceutical Espana SL.
                                     Sinclair Pharmaceuticals (Asia Pacific) Pte. Ltd
                                     Sinclair Pharmaceuticals Limited
                                     Sinclair Pharmaceuticals Limited Singapore Branch
                                     Sinclair Pharmaceuticals Limited Sp. z o.o.

                                     Sinclair Lifesciences India Private Ltd
                                     Speciality European Pharma International AG

                                     Viora Inc.
                                     Viora Canada Ltd
                                     Viora Ltd

Alan Olby resigned as a director of Speciality European Pharma International
AG in the 12 months prior to the company going into liquidation on 29 November
2018.

Other than the award of share options, as noted below, Alan Olby has no
existing interest in the ordinary shares of the Company.

There are no further disclosures to be made under Schedule 2(g) of the AIM
Rules for Companies.

 

Grant of Options

Alan Olby has been granted a total of 222,222 nil cost options over ordinary
shares of 10 pence each in the capital of the Company ("Options") under the
Inspiration Healthcare Group Long Term Incentive Plan as detailed below.

 

The Options are exercisable at nil cost and are subject to continuous
employment with the Company for a period of three years ending on 11 June
2026.

 

 

 

 Inspiration Healthcare Group plc                                                       Tel: +44 (0)330
                                                        175 0000
 Neil Campbell, Chief Executive Officer

 Liberum (Nominated Adviser & Broker)                                                   Tel: +44 (0)20
                                                        3100 2000
 Phil Walker, Richard Lindley, William Hall, Will King

 Walbrook PR Ltd (Media and Investor Relations)                                         Tel: +44 (0)20
                                                        7933 8780
 Anna Dunphy/Stephanie Cuthbert

 

 

 1     Details of the person discharging managerial responsibilities / person closely
       associated
 a)    Name                                                         1.  Alan Olby
 2     Reason for the notification
 a)    Position/status                                              1.  PDMR (CFO)
 b)    Initial notification /Amendment                              Initial
 3     Details of the issuer, emission allowance market participant, auction
       platform, auctioneer or auction monitor
 a)    Name                                                         Inspiration Healthcare Group plc
 b)    LEI                                                          213800GKFT3ENAPMDL15
 4     Details of the transaction(s): section to be repeated for (i) each type of

     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
       place where transactions have been conducted
 a)    Description of the financial instrument, type of instrument  Options over Ordinary Shares of 10p each in the capital of the Company

       Identification code                                          ISIN: GB00BXDZL105
 b)    Nature of the transaction                                    Grant of Options under the Long Term Incentive Plan
 c)    Price(s) and volume(s)                                       Price(s)  Volume(s)

                                                            1. Nil    1. 222,222

 d)    Aggregated information

       -Aggregated volume                                           N/A - single transaction

       - Price
 e)    Date of the transaction                                      12 June 2023
 f)    Place of the transaction                                     Outside of a trading venue

d)

 

Aggregated information

-Aggregated volume

- Price

 

N/A - single transaction

 

e)

Date of the transaction

12 June 2023

f)

Place of the transaction

Outside of a trading venue

 

About Inspiration Healthcare

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology
for use in neonatal intensive care & operating theatres. The Company
provides high quality innovative products to patients around the world which
help to improve patient outcomes and it actively invests in innovative product
opportunities and disruptive technologies.

 

The Company has key own brand products that can be used within the first days
of life to help premature and sick babies; helping resuscitation and
stabilisation in the first moments of life through to preventing brain damage
and both invasive and non-invasive respiratory support in terms of capital
equipment and disposable medical devices. Additionally, the Company has its
own range of products for maintaining normothermia pre, during and
post-surgery.

 

Since September 2019, the Company has acquired Vio Holdings a designer,
manufacturer and supplier of single use respiratory products and sterile
medical consumables and S.L.E., a leading designer, manufacturer and global
provider of neonatal ventilation products.  The Group generates approximately
58% of its revenues from export markets and more than half of its revenues
come from its own-branded products.

 

With product availability actively promoted to over 80 countries through a
distribution network, Inspiration Healthcare's success has been built on
continuous innovation, excellent customer service and an inherent commitment
to improving patient outcomes, working in close collaboration with key opinion
leaders across the globe.

 

In the UK and Ireland, the Group has direct sales teams selling Group Branded
and complementary products from third parties, with an additional range of
home healthcare products.  This is supported by Technical Support for planned
preventative maintenance and emergency assistance.

 

The Group operates from various sites in the UK for R&D, Marketing and
operations with manufacturing based in Croydon (south London) and Hailsham
(East Sussex).  The Group's Head Office is located in Crawley, a short
distance from London's Gatwick Airport.

 

Further information on Inspiration Healthcare can be found at
www.inspirationhealthcaregroup.com (http://www.inspirationhealthcaregroup.com)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOASFWFSFEDSEFM